Will Nike's Stock Price Sink to $23? Here Are the Bear, Base, and Bull Cases Over the Next Year.

Nike shares have fallen nearly 50% over the past 12 months, and analyst targets span $23 to $75 versus a $36.80 Sept. 11 close, implying downside of 37.5% or upside of 103.8%. Fiscal 2026 Greater China revenue declined 11% to $5.8 billion and Converse sales fell 31% to $1.2 billion, offset partly by a 6% increase in wholesale revenue to $27.5 billion. The median analyst target is $46, or 25% upside, but the article argues investors should wait for sustained turnaround evidence before buying.

Analysis

NKE’s valuation debate is less about the headline China decline than whether the wholesale rebuild can restore full-price sell-through without reigniting promotional intensity. A wholesale-led recovery can lift revenue visibility over the next 1-3 quarters, but it is margin-dilutive if partners demand markdown support or if Nike uses the channel to clear excess inventory. The investable KPI is therefore gross-margin progression alongside wholesale growth, not wholesale growth alone.

China is also a competitive-positioning problem rather than merely a macro variable: domestic brands such as Anta Sports and Li Ning have gained local relevance, while Adidas and New Balance compete aggressively in global running and lifestyle. A sustained share loss would impair Nike’s regional pricing power and make a rapid earnings-multiple rerating unlikely even if reported sales stabilize. Converse weakness matters disproportionately as evidence that brand revitalization has not yet broadened beyond the core Nike franchise.

Consensus caution leaves room for a tactical upside move if the next two reports show sequential China stabilization, improving digital/full-price mix, and gross-margin upside. But the article’s disparate price targets are not an analytical catalyst; they mainly expose a wide range of unvalidated turnaround assumptions. Over 6-18 months, product innovation must translate into measurable sell-through and reduced discounting, or NKE risks becoming a low-growth branded-apparel asset valued on a structurally lower multiple.

The contrarian downside is that investors may be treating the turnaround as binary and underestimating a middle outcome: modest sales recovery paired with persistently weak margins. That outcome can support the shares near current levels but offers limited reason for a durable rerating. Falsify the cautious thesis with two consecutive quarters of China growth, wholesale acceleration without gross-margin erosion, and management raising—not merely reaffirming—profit guidance.

Key Decisions for Investors

• Remain tactically neutral on NKE into the next earnings release; upgrade to a 3-6 month long only after evidence of China stabilization and gross-margin expansion in the same quarter. A post-results entry following confirmation offers better risk-adjusted exposure than underwriting an unproven turnaround today.
• For existing long exposure, use a collar: retain NKE shares while buying 6-9 month downside puts and financing part of the premium with calls near the optimistic sell-side valuation range. This preserves upside if the turnaround validates while limiting exposure to another guidance reset.
• Watch a relative-value long NKE / short a broad discretionary ETF such as XLY only if company-specific operating KPIs improve; this isolates execution recovery from consumer-spending and market-beta risk. Exit if gross margin declines despite wholesale growth, signaling channel mix is masking weak demand.
• Monitor Anta Sports and Li Ning sales trends, China athletic-footwear discounting, and Nike inventory/receivables growth as leading indicators. Reassess bearish positioning if regional competitors weaken simultaneously, which would indicate macro demand pressure rather than a Nike-specific share-loss problem.